bioganix ltd

Live MatureMidHigh

bioganix ltd Company Information

Share BIOGANIX LTD

Company Number

05240586

Shareholders

bioganix (holdings) ltd

Group Structure

View All

Industry

Treatment and disposal of non-hazardous waste

 

Registered Address

bonby lane bonby, brigg, north lincolnshire, DN20 0PJ

bioganix ltd Estimated Valuation

£10.1m

Pomanda estimates the enterprise value of BIOGANIX LTD at £10.1m based on a Turnover of £12.9m and 0.79x industry multiple (adjusted for size and gross margin).

bioganix ltd Estimated Valuation

£2.9m

Pomanda estimates the enterprise value of BIOGANIX LTD at £2.9m based on an EBITDA of £586.1k and a 4.89x industry multiple (adjusted for size and gross margin).

bioganix ltd Estimated Valuation

£4.7m

Pomanda estimates the enterprise value of BIOGANIX LTD at £4.7m based on Net Assets of £1.9m and 2.55x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Bioganix Ltd Overview

Bioganix Ltd is a live company located in north lincolnshire, DN20 0PJ with a Companies House number of 05240586. It operates in the treatment and disposal of non-hazardous waste sector, SIC Code 38210. Founded in September 2004, it's largest shareholder is bioganix (holdings) ltd with a 100% stake. Bioganix Ltd is a mature, mid sized company, Pomanda has estimated its turnover at £12.9m with high growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Bioganix Ltd Health Check

Pomanda's financial health check has awarded Bioganix Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

3 Strong

positive_score

5 Regular

positive_score

4 Weak

size

Size

annual sales of £12.9m, make it in line with the average company (£15.3m)

£12.9m - Bioganix Ltd

£15.3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (8.4%)

20% - Bioganix Ltd

8.4% - Industry AVG

production

Production

with a gross margin of 25.6%, this company has a comparable cost of product (25.6%)

25.6% - Bioganix Ltd

25.6% - Industry AVG

profitability

Profitability

an operating margin of 1.6% make it less profitable than the average company (9.2%)

1.6% - Bioganix Ltd

9.2% - Industry AVG

employees

Employees

with 37 employees, this is similar to the industry average (42)

37 - Bioganix Ltd

42 - Industry AVG

paystructure

Pay Structure

on an average salary of £43.7k, the company has an equivalent pay structure (£43.7k)

£43.7k - Bioganix Ltd

£43.7k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £347.5k, this is more efficient (£250.4k)

£347.5k - Bioganix Ltd

£250.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 46 days, this is later than average (33 days)

46 days - Bioganix Ltd

33 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 38 days, this is slower than average (27 days)

38 days - Bioganix Ltd

27 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 5 days, this is more than average (3 days)

5 days - Bioganix Ltd

3 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 5 weeks, this is less cash available to meet short term requirements (18 weeks)

5 weeks - Bioganix Ltd

18 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 74.9%, this is a similar level of debt than the average (69.5%)

74.9% - Bioganix Ltd

69.5% - Industry AVG

BIOGANIX LTD financials

EXPORTms excel logo

Bioganix Ltd's latest turnover from March 2024 is estimated at £12.9 million and the company has net assets of £1.9 million. According to their latest financial statements, Bioganix Ltd has 37 employees and maintains cash reserves of £229.7 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover12,857,38711,756,81610,393,1407,421,7285,134,4625,160,1664,157,9852,967,9762,148,4075,401,6964,294,3402,394,8281,493,7641,356,611812,728
Other Income Or Grants
Cost Of Sales9,565,0678,999,5257,754,2775,697,9103,973,5244,116,9053,284,5882,328,7981,680,3094,368,6443,448,8121,941,2561,181,2371,035,354647,952
Gross Profit3,292,3202,757,2912,638,8631,723,8171,160,9371,043,261873,396639,178468,0981,033,052845,528453,572312,527321,258164,775
Admin Expenses3,089,2001,249,1111,573,759715,4771,995,323384,937221,125173,884253,470846,714908,934700,478433,322396,744318,141
Operating Profit203,1201,508,1801,065,1041,008,340-834,386658,324652,271465,294214,628186,338-63,406-246,906-120,795-75,486-153,366
Interest Payable231,455287,602234,332213,335202,581219,632201,672187,11397,299
Interest Receivable40,58343,4213,869152565626166178224179108116212152
Pre-Tax Profit12,2481,263,999834,641795,157-1,036,966439,257451,225278,346117,508186,562-63,227-246,798-120,679-75,274-153,214
Tax-3,062-240,160-158,582-151,080-83,459-85,733-55,669-23,501-39,178
Profit After Tax9,1861,023,839676,059644,077-1,036,966355,798365,492222,67794,006147,384-63,227-246,798-120,679-75,274-153,214
Dividends Paid
Retained Profit9,1861,023,839676,059644,077-1,036,966355,798365,492222,67794,006147,384-63,227-246,798-120,679-75,274-153,214
Employee Costs1,615,7491,112,903951,246829,499851,166746,200732,926455,172408,576673,654500,556295,073197,885165,327107,765
Number Of Employees372725232322221513221710764
EBITDA*586,0691,880,9261,419,2941,337,526-538,363908,247873,192623,422214,628319,71949,991-139,149-34,15418,042-70,377

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets5,022,2693,492,3633,016,3204,928,3454,523,3794,071,3394,064,5983,525,6922,457,3432,215,9382,225,4372,079,2901,729,9551,357,9191,274,780
Intangible Assets
Investments & Other20020020020020020022020
Debtors (Due After 1 year)
Total Fixed Assets5,022,4693,492,5633,016,5204,928,5454,523,5794,071,5394,064,8183,525,7122,457,3432,215,9382,225,4372,079,2901,729,9551,357,9191,274,780
Stock & work in progress135,10791,021102,34766,0784,9004,9004,900
Trade Debtors1,626,5321,737,0811,944,0841,259,607763,685751,783555,175376,050223,394834,867366,922293,375137,240237,632133,002
Group Debtors25,646103,291104,395218,331123,017832,711288,823
Misc Debtors340,525495,646113,38889,055308,191616,502342,040154,538400,151
Cash229,6721,316,338727,008304,69129799149,808100,43232,32038,93050,66020,85822,41124,17760,675
misc current assets
total current assets2,357,4823,743,3772,991,2221,937,7621,199,8222,206,6951,340,746631,020655,865873,797417,582314,233159,651261,809193,677
total assets7,379,9517,235,9406,007,7426,866,3075,723,4016,278,2345,405,5644,156,7323,113,2083,089,7352,643,0192,393,5231,889,6061,619,7281,468,457
Bank overdraft138,2634,667
Bank loan211,972155,360146,062122,025
Trade Creditors 1,016,1091,136,354680,232399,371343,324425,692354,767345,316227,050440,926564,310246,927236,045113,32953,314
Group/Directors Accounts20020020010010025,40525,40525,3057,755
other short term finances
hp & lease commitments560,678380,495265,628254,314235,569118,015116,84480,743139,83898,108102,419109,58765,08625,0998,567
other current liabilities292,970264,652285,035780,582785,193551,731252,14459,14928,411
total current liabilities2,081,9291,937,0611,377,1571,556,3921,502,4491,125,510749,160510,513403,054539,034666,729356,514301,131138,42861,881
loans1,585,4512,161,9693,148,3583,526,7223,207,5883,291,4783,211,4782,993,8142,993,814
hp & lease commitments1,268,927766,403410,239393,159471,978215,311217,43643,400124,14271,895170,003272,423192,64225,7887,790
Accruals and Deferred Income
other liabilities2,980,6142,455,4792,350,5511,735,0001,674,0001,542,000
provisions591,284527,333252,653218,094149,925217,508154,861117,277
total long term liabilities3,445,6623,455,7053,811,2504,137,9753,829,4913,724,2973,583,7753,154,4913,117,9563,052,5092,625,4822,622,9741,927,6421,699,7881,549,790
total liabilities5,527,5915,392,7665,188,4075,694,3675,331,9404,849,8074,332,9353,665,0043,521,0103,591,5433,292,2112,979,4882,228,7731,838,2161,611,671
net assets1,852,3601,843,174819,3351,171,940391,4611,428,4271,072,629491,728-407,802-501,808-649,192-585,965-339,167-218,488-143,214
total shareholders funds1,852,3601,843,174819,3351,171,940391,4611,428,4271,072,629491,728-407,802-501,808-649,192-585,965-339,167-218,488-143,214
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit203,1201,508,1801,065,1041,008,340-834,386658,324652,271465,294214,628186,338-63,406-246,906-120,795-75,486-153,366
Depreciation382,949372,746354,190329,186296,023249,923220,921158,128133,381113,397107,75786,64193,52882,989
Amortisation
Tax-3,062-240,160-158,582-151,080-83,459-85,733-55,669-23,501-39,178
Stock44,086-11,32636,26961,1784,900
Debtors-343,315174,151594,874372,100-1,006,1031,014,958655,450-92,957-211,322467,94573,547156,135-100,392104,630133,002
Creditors-120,245456,122280,86156,047-82,36870,9259,451118,266-213,876-123,384317,38310,882122,71660,01553,314
Accruals and Deferred Income28,318-20,383-495,547-4,611233,462299,587192,99530,73828,411
Deferred Taxes & Provisions63,951274,68034,55968,169-67,58362,64737,584117,277
Cash flow from operations854,2602,188,360449,442872,773551,251242,989367,139926,991216,984-310,788293,827-284,402188,954-26,573-150,065
Investing Activities
capital expenditure-1,912,855-848,7891,557,835-734,152-748,063-256,664-759,827-1,226,477-241,405-123,882-259,544-457,092-458,677-176,667-1,357,769
Change in Investments-2020020
cash flow from investments-1,912,855-848,7891,557,835-734,152-748,063-256,644-760,027-1,226,497-241,405-123,882-259,544-457,092-458,677-176,667-1,357,769
Financing Activities
Bank loans56,6129,29824,037122,025
Group/Directors Accounts100-25,30510017,5507,755
Other Short Term Loans
Long term loans-576,518-986,389-378,364319,134-83,89080,000217,6642,993,814
Hire Purchase and Lease Commitments682,707471,03128,394-60,074374,221-954210,137-139,83793,977-102,419-109,588124,282206,84134,53016,357
other long term liabilities-2,980,614525,135104,928615,55161,000132,0001,542,000
share issue-1,028,664136,402215,409676,85310,000
interest-190,872-244,181-230,463-213,183-202,581-219,067-201,046-186,947-97,121224179108116212152
cash flow from financing-28,071-750,241-1,584,960304,30462,445-140,021442,264367,61917,811422,940-4,481739,941267,957166,7421,568,509
cash and cash equivalents
cash-1,086,666589,330422,317304,662-770-149,00949,37668,112-6,610-11,73029,802-1,553-1,766-36,49860,675
overdraft-138,263133,5964,667
change in cash-1,086,666589,330422,317442,925-134,366-153,67649,37668,112-6,610-11,73029,802-1,553-1,766-36,49860,675

bioganix ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for bioganix ltd. Get real-time insights into bioganix ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Bioganix Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for bioganix ltd by selecting its closest rivals, whether from the WATER SUPPLY; SEWERAGE, WASTE MANAGEMENT AND REMEDIATION ACTIVITIES sector, other mid companies, companies in DN20 area or any other competitors across 12 key performance metrics.

bioganix ltd Ownership

BIOGANIX LTD group structure

Bioganix Ltd has 2 subsidiary companies.

Ultimate parent company

BIOGANIX LTD

05240586

2 subsidiaries

BIOGANIX LTD Shareholders

bioganix (holdings) ltd 100%

bioganix ltd directors

Bioganix Ltd currently has 3 directors. The longest serving directors include Mr Lewis Dodds (Sep 2004) and Mr Christopher White (Nov 2012).

officercountryagestartendrole
Mr Lewis DoddsEngland59 years Sep 2004- Director
Mr Christopher WhiteEngland53 years Nov 2012- Director
Mr Clive TylerUnited Kingdom67 years Nov 2012- Director

P&L

March 2024

turnover

12.9m

+9%

operating profit

203.1k

0%

gross margin

25.7%

+9.18%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

1.9m

0%

total assets

7.4m

+0.02%

cash

229.7k

-0.83%

net assets

Total assets minus all liabilities

bioganix ltd company details

company number

05240586

Type

Private limited with Share Capital

industry

38210 - Treatment and disposal of non-hazardous waste

incorporation date

September 2004

age

21

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

March 2024

previous names

bio waste solutions limited (February 2017)

bio waste solutions ltd (October 2004)

accountant

TOWNENDS ACCOUNTANTS LLP

auditor

-

address

bonby lane bonby, brigg, north lincolnshire, DN20 0PJ

Bank

HSBC BANK PLC

Legal Advisor

SILLS & BETTERIDGE LLP

bioganix ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 6 charges/mortgages relating to bioganix ltd. Currently there are 3 open charges and 3 have been satisfied in the past.

bioganix ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for BIOGANIX LTD. This can take several minutes, an email will notify you when this has completed.

bioganix ltd Companies House Filings - See Documents

datedescriptionview/download